Policy Brief: Anti-Microbial Resistance In India: Are Magic Bullets Eroded

Abstract

Antimicrobial resistance (AMR), also known as drug resistance, occurs when microorganisms such as bacteria, viruses, fungi, and parasites evolve in ways that render the medications used to cure the infections they cause ineffective [1]. When the microorganisms become resistant to most antimicrobials, they are often referred to as "superbugs" [1]. AMR is a major public health concern because a resistant infection may kill, can spread to others, and imposes a huge cost on individuals and society [1]. Therefore, this policy brief presents a situational analysis of AMR and advocates for a multi-disciplinary approach to control AMR in India. The most recent and relevant publications on AMR in India were reviewed and analyzed to recommend a comprehensive health policy framework. The study recommends an innovative health policy framework for avoiding emergence, supporting research and development (R&D) for new drugs, and encouraging multi-sectoral coordination. Further amendments to the existing health policy with a targeted approach to prevent the growing epidemic of AMR are required. Failure to do so may cause irreversible damage with high morbidity, mortality, and disability in India.